SureTrader Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: nanopatent, TomP1
Search This Board:
Last Post: 7/27/2016 11:10:51 AM - Followers: 410 - Board type: Free - Posts Today: 7

Logo: Inovio

ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE-

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13499   Thanks, always looking for something interesting: nanopatent 07/27/16 11:10:51 AM
#13498  Restored Worth following, not as impressive as INO but Dr_Thorfin 07/27/16 10:51:54 AM
#13497  Restored ELTP Elite Pharmaceuticals, Inc. 10:31am EDT 0.1449 Down 0.0121 4,558,974 nanopatent 07/27/16 10:48:47 AM
#13496   "Netflix was never this good." Big pharma will be Dr_Thorfin 07/27/16 10:39:22 AM
#13495   Realy undervalued at 9 dollar nanopatent 07/27/16 10:24:57 AM
#13494   And thats just for zika Pipeline is worth Billions Realy Dr_Thorfin 07/27/16 10:18:18 AM
#13493   Zika vaccine = preventative AND therapeutic, IOW it nanopatent 07/27/16 09:58:53 AM
#13492   Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the dosing Dr_Thorfin 07/26/16 05:20:42 PM
#13491   These volunteers would be great ushers at the Olympics!! nanopatent 07/26/16 02:44:36 PM
#13490   Zika virus vaccine Phase I clinical trial on nanopatent 07/20/16 05:28:43 PM
#13489   Nice to see this news today, quiet AnonymousInvestor 07/14/16 09:59:00 PM
#13488   Congress just adjourned for 7 weeks without agreeing rwpauli 07/14/16 07:53:05 PM
#13487   I do like the possibilities from this effort: nanopatent 07/14/16 08:32:15 AM
#13486   Next stop, $7.00? arvitar 07/13/16 10:12:59 PM
#13485 starman2 07/10/16 12:17:53 PM
#13484   At this time of year I love weiners....especially nanopatent 07/08/16 12:32:25 PM
#13483   20% here, 100% there, in the final analysis, nanopatent 07/08/16 12:29:34 PM
#13482   INO down 20% in the past month. arvitar 07/08/16 12:26:09 PM
#13481 nanopatent 07/08/16 08:32:00 AM
#13480   Any day now!!! nanopatent 07/08/16 08:29:27 AM
#13478   I do try to be careful, thank you nanopatent 07/08/16 08:26:58 AM
#13477   Tomorrow INO will leg up +4%. IMO Silvr Surfr 07/05/16 03:02:14 PM
#13476   Agreed. Good to see ya round.. YankeeDolphin 07/01/16 11:04:22 AM
#13475   Stock is looking to rip higher on Zika Silvr Surfr 07/01/16 09:52:35 AM
#13473   LoL--Color blind to GREEN only... Win a few YankeeDolphin 06/30/16 03:42:48 PM
#13472   I didn't know UP was RED . kpisme 06/30/16 03:21:25 PM
#13469   Here's Why Wall Street Is Buzzing About Inovio nanopatent 06/29/16 09:26:45 AM
#13468   How An Electric Shock Could One Day Protect nanopatent 06/29/16 09:22:38 AM
#13467   * * $INO Video Chart 06-28-16 * * ClayTrader 06/28/16 05:13:44 PM
#13466   Looks bad but we know where it's going. gfunk15 06/28/16 12:56:17 PM
#13465   Interview: How This Homegrown Philly Biotech Co. Is nanopatent 06/24/16 08:20:44 PM
#13464   Fast Track designation must be requested by the nanopatent 06/22/16 06:55:46 PM
#13463   Depends how serious the spread becomes in the TomP1 06/22/16 06:15:37 PM
#13462   Factually wrong as it assumes that Sanofi was TomP1 06/22/16 06:14:39 PM
#13461   Equity analysts that regularly cover Inovio Pharmaceuticals, Inc. nanopatent 06/22/16 05:34:58 PM
#13460   Then Kim will be late as usual. kpisme 06/22/16 03:47:30 PM
#13459   Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review nanopatent 06/22/16 03:18:59 PM
#13458   Zika vaccine - Kim - "It could take nanopatent 06/22/16 03:01:19 PM
#13457   Inovio Pharmaceuticals Jumps Ahead Of Sanofi In Zika trendmkr 06/22/16 02:04:36 PM
#13456   I'm going to hold BOTH halves!! nanopatent 06/22/16 12:54:21 PM
#13455   Cramer this morning said to sell half and rustynail 06/22/16 12:51:52 PM
#13454   No idea but a short attack is likely. nanopatent 06/22/16 10:30:32 AM
#13453   Is this price drop a sell the news, DrStockonomics 06/22/16 10:28:53 AM
#13452   Wow, life is certainly not dull with INO nanopatent 06/22/16 10:25:20 AM
#13451   New seeking alpha article Perkin78 06/22/16 10:02:01 AM
#13450 Apenny 06/21/16 01:41:51 PM
#13449   LOCAL FIRM GETS GREEN LIGHT TO TEST ZIKA nanopatent 06/21/16 11:12:28 AM
#13448  Restored Life sucks! nanopatent 06/21/16 10:49:27 AM
#13446   What is the major scourge of mankind? nanopatent 06/21/16 10:23:26 AM
#13445   If you doubled down at $5 you would Perkin78 06/21/16 09:33:52 AM